The study will assess the total testosterone and sex hormone-binding globulin levels in men with type 2 diabetes before and after continuous subcutaneous insulin infusion and hypoglycemic drugs treatment.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
74
Continuous subcutaneous insulin infusion therapy for 1 month
Continuous subcutaneous insulin infusion plus metformin (at least1000mg/day) for 1 month
Continuous subcutaneous insulin infusion plus metformin (10mg/day) for 1 month
Nanjing First Hospital
Nanjing, China
total testosterone levels
changes of total testosterone levels
Time frame: 1 month
bioavailable testosterone
changes of bioavailable testosterone
Time frame: 1 month
free testosterone
changes of free testosterone
Time frame: 1 month
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.